Dexmedetomidine's Potential: Dexmedetomidine (Dex), an α2-adrenergic receptor agonist, shows promise in modulating macrophage functions and reducing inflammatory responses in sepsis, warranting further investigation into its combined effects on macrophage proliferation, phagocytosis, and cytokine secretion.